Submission Details
| 510(k) Number | K950227 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 10, 1995 |
| Decision Date | August 15, 1995 |
| Days to Decision | 217 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K950227 is an FDA 510(k) clearance for the RUBELISA (RUBESTAT), a Enzyme Linked Immunoabsorbent Assay, Rubella (Class II — Special Controls, product code LFX), submitted by Bio-Whittaker, Inc., A Cambrex Co. (Walkersville, US). The FDA issued a Cleared decision on August 15, 1995, 217 days after receiving the submission on January 10, 1995. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3510.
| 510(k) Number | K950227 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 10, 1995 |
| Decision Date | August 15, 1995 |
| Days to Decision | 217 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | LFX — Enzyme Linked Immunoabsorbent Assay, Rubella |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3510 |